169 related articles for article (PubMed ID: 11214878)
1. Labelling of Re-ABP with 188Re for bone pain palliation.
Arteaga de Murphy C; Ferro-Flores G; Pedraza-López M; Meléndez-Alafort L; Croft BY; Ramírez FM; Padilla J
Appl Radiat Isot; 2001 Mar; 54(3):435-42. PubMed ID: 11214878
[TBL] [Abstract][Full Text] [Related]
2. 188Re(CO)3-dipicolylamine-alendronate: a new bisphosphonate conjugate for the radiotherapy of bone metastases.
Torres Martin de Rosales R; Finucane C; Foster J; Mather SJ; Blower PJ
Bioconjug Chem; 2010 May; 21(5):811-5. PubMed ID: 20387897
[TBL] [Abstract][Full Text] [Related]
3. Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.
Lin WY; Lin CP; Yeh SJ; Hsieh BT; Tsai ZT; Ting G; Yen TC; Wang SJ; Knapp FF; Stabin MG
Eur J Nucl Med; 1997 Jun; 24(6):590-5. PubMed ID: 9169563
[TBL] [Abstract][Full Text] [Related]
4. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies.
Blower PJ; Lam AS; O'Doherty MJ; Kettle AG; Coakley AJ; Knapp FF
Eur J Nucl Med; 1998 Jun; 25(6):613-21. PubMed ID: 9618576
[TBL] [Abstract][Full Text] [Related]
5. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation.
Oh SJ; Won KS; Moon DH; Cheon JH; Ha HJ; Jeong JM; Lee HK
Nucl Med Commun; 2002 Jan; 23(1):75-81. PubMed ID: 11748441
[TBL] [Abstract][Full Text] [Related]
6. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina CE; Sepúlveda-Méndez J
Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
[TBL] [Abstract][Full Text] [Related]
7. Preparation of (188Re) Re-AEDP and its biodistribution studies.
Qingnuan L; Xiaodong Z; Rong S; Wenxin L
Appl Radiat Isot; 2000 Dec; 53(6):993-7. PubMed ID: 11077963
[TBL] [Abstract][Full Text] [Related]
8. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.
Knapp FF; Beets AL; Guhlke S; Zamora PO; Bender H; Palmedo H; Biersack HJ
Anticancer Res; 1997; 17(3B):1783-95. PubMed ID: 9179235
[TBL] [Abstract][Full Text] [Related]
9. Rhenium-188-HEDP in the palliative treatment of bone metastases.
Liepe K; Hliscs R; Kropp J; Grüning T; Runge R; Koch R; Knapp FF; Franke WG
Cancer Biother Radiopharm; 2000 Jun; 15(3):261-5. PubMed ID: 10941533
[TBL] [Abstract][Full Text] [Related]
10. Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy.
Lambert B; de Klerk JM
Nucl Med Commun; 2006 Mar; 27(3):223-9. PubMed ID: 16479241
[TBL] [Abstract][Full Text] [Related]
11. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
Palmedo H; Grünwald F; Wagner U; Köhler S; Krebs D; Biersack HJ
Clin Nucl Med; 1998 Aug; 23(8):501-4. PubMed ID: 9712380
[TBL] [Abstract][Full Text] [Related]
12. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Liepe K; Kropp J; Hliscs R; Franke WG
Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
[TBL] [Abstract][Full Text] [Related]
13. 99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution.
Ballot S; Noiret N; Hindré F; Denizot B; Garin E; Rajerison H; Benoit JP
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):602-7. PubMed ID: 16450136
[TBL] [Abstract][Full Text] [Related]
14. [Radionuclide therapy for bone metastases by drugs based on Re-188].
Liepe K; Krylov VV; Kochetova TY
Vopr Onkol; 2016; 62(4):401-9. PubMed ID: 30474946
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
Liepe K; Franke WG; Kropp J; Koch R; Runge R; Hliscs R
Nuklearmedizin; 2000 Sep; 39(6):146-51. PubMed ID: 11057405
[TBL] [Abstract][Full Text] [Related]
16. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
Maxon HR; Schroder LE; Hertzberg VS; Thomas SR; Englaro EE; Samaratunga R; Smith H; Moulton JS; Williams CC; Ehrhardt GJ
J Nucl Med; 1991 Oct; 32(10):1877-81. PubMed ID: 1717669
[TBL] [Abstract][Full Text] [Related]
17. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
18. A Freeze-Dried Kit for the Preparation of (188)Re-HEDP for Bone Pain Palliation: Preparation and Preliminary Clinical Evaluation.
Mallia MB; Shinto AS; Kameswaran M; Kamaleshwaran KK; Kalarikal R; Aswathy KK; Banerjee S
Cancer Biother Radiopharm; 2016 May; 31(4):139-44. PubMed ID: 27183437
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.
Palmedo H; Guhlke S; Bender H; Sartor J; Schoeneich G; Risse J; Grünwald F; Knapp FF; Biersack HJ
Eur J Nucl Med; 2000 Feb; 27(2):123-30. PubMed ID: 10755716
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina C; Sepúlveda-Méndez J
Arch Med Res; 1996; 27(4):481-3. PubMed ID: 8987181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]